Genscript Biotech Market Cap

Genscript Biotech has a market cap or net worth of 24.25 billion as of March 13, 2026. Its market cap has decreased by -9.08% in one year.

Market Cap

24.25B

Enterprise Value

21.23B

Revenue

6.50B

Ranking

n/a

PE Ratio

0.99

Stock Price

11.09

Market Cap Chart

Since December 30, 2015, Genscript Biotech's market cap has increased from 2.11B to 24.25B, an increase of 1,048.13%. That is a compound annual growth rate of 27.01%.

Market Cap History

Date	Market Cap	% Change
Mar 13, 2026	24.25B	-10.70%
Dec 31, 2025	27.15B	28.72%
Dec 31, 2024	21.10B	-49.96%
Dec 29, 2023	42.16B	-19.78%
Dec 30, 2022	52.56B	-27.50%
Dec 31, 2021	72.50B	229.03%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Shanghai Henlius Biotech	36.77B
Biocytogen Pharmaceuticals (Beijing)	35.97B
Shanghai Junshi Biosciences	32.35B
TransThera Sciences (Nanjing)	30.08B
Duality Biotherapeutics	26.18B
InnoCare Pharma	23.89B
PegBio	21.00B
Ascentage Pharma Group International	17.38B

Market Cap Rankings